ArteraAI Test: it seems that all... - Prostate Cancer N...

Prostate Cancer Network

5,265 members3,332 posts

ArteraAI Test

Bourbon2024 profile image
12 Replies

it seems that all prostate cancer patients with localized tumor(s) with Intermediate Risk should receive the ArteraAI test to prognosticate/predict how ADT would impact 5, 10, 15 years metastasis. It seems about 2/3 of these patients do not receive any added benefit from ADT therapy.

There are many tests to provide more understanding on a patients prostate cancer that can help determine appropriate treatment modalities. Patients should learn about all available tests and insist they receive them. (Decipher, Artera, Prostox, PSMA, etc. )

Written by
Bourbon2024 profile image
Bourbon2024
To view profiles and participate in discussions please or .
Read more about...
12 Replies
Tall_Allen profile image
Tall_Allen

The problem with Artera AI is the endpoint they chose - metastasis free survival at up to 15 years. That is fine if you are 80 years old or you have other health concerns. But for the average intermediate-risk man who has failed after a prostatectomy at 60 years of age, he is more interested in being cured with salvage radiation. If he can be cured with 4-6 months of adjuvant ADT now, he can be spared the pain and crippling of getting metastases 20 years later.

Bourbon2024 profile image
Bourbon2024 in reply toTall_Allen

I don’t know how these various tests perform and compare when done on patient with no previous treatment of any kind vs treatment - RT, RP, chemo

RugbyVLS profile image
RugbyVLS

Unfortunately they are not yet able to make that determination (despite publicity to the contrary). We had them run the test and the only thing they could say was "you are high risk". We knew that based on PSA, Gleason, Decipher, etc. They said they hoped to have the the predictive capabilities about length of adt available by the end of 2024.

janebob99 profile image
janebob99 in reply toRugbyVLS

That's interesting (and concerning). I'm thinking of getting the Artera test to see if I'm one of the 66% of men that don't benefit from doing ADT. But, it sounds like they didn't provide that information to you. Am I understanding your post correctly?

RugbyVLS profile image
RugbyVLS in reply tojanebob99

Correct. This was what we were told: "While the test did confirm you have high risk disease, it unfortunately did not provide us with the answer we were looking for on long versus short course of therapy.

Dr. xxxxx did speak with one of the representatives at Artera who confirmed this feature will not be available until the end of 2024."

janebob99 profile image
janebob99 in reply toRugbyVLS

Thanks. Did they give you any advice on whether or not to do ADT at all (independent of the question if you should do long or short course ADT)?

RugbyVLS profile image
RugbyVLS in reply tojanebob99

Didn't ask that question as ADT was indicated with high risk. Our only question was how long. Many of the studies say short term is 6 months or less, but when referring to "long term", that can sometimes be 12, 18, 24 or even 36 months. We were hoping that Artera could lend some clarity.

janebob99 profile image
janebob99 in reply toRugbyVLS

Got it. I have the same questions.

You may want to look into doing estrogen patch therapy (EPT). It doesn't have the problems with the previously used Oral estrogen therapy. There's a current phase-III study (PATCH trial) that is showing very favorable results, compared to Lupron injections. The long-term final results should be published this Spring. EPT still castrates you the same as Lupron, but EPT doesn't have the bad side effects of Lupron ADT. In particular, doing EPT has no osteoporosis, no lipid changes, no increased fat deposition, no increased insulin resistance, no memory loss, and no hot flashes. EPT does not help with ED or loss of muscle mass/strength, however. I don't know about libido side effects, though.

If you send me your email address, I will send you 10 papers on recent estrogen patch therapy.

Bob

Mgtd profile image
Mgtd in reply tojanebob99

Bob I am the guy who discussed the AI test results in the NEJM. After reading the above post I just wanted to mention that you hopefully are not confusing short vs long term effects on ADT use.

All those scary things you mentioned like heart issues, bone loss, etc are found in long term ADT use. These are not a short term ADT issues.

It sounds like you are still in the preliminary decision phase so here are my thoughts and experiences on radiation and short term ADT impact and how I overcame them.

Regarding your ability to overcome weight gain, ADT and radiation fatigue, muscle loss and hot flashes on ADT in my experience by watching your calorie intake and doing resistance training and HIIT or extended Phase II workouts you can overcome those issues or at least reduce them to a manageable level.

Once again in my limited experience doing that allowed me to lose 12 pounds and drop 2” off my waist. Although I was not really out of shape for someone who is almost 80 I am now weight and muscle development wise back to where I was playing college ball some 60 years ago.

If you decide to go that physical and diet enhancement route I would suggest you start immediately for best results. It takes time to develop good habits and consistency.

Really nice talking with you and best of luck with your decision making and overall results.

Joe

janebob99 profile image
janebob99 in reply toMgtd

Thanks, Joe.

I appreciate the feedback. That's a good point that the side-effects of short-term ADT are less worse than long-term ADT. I'm currently going to the gym 3 days a week, but will likely have to increase that to 5-6 days a week when on ADT. I convinced Dr. Kishan at UCLA to replace standard Lupron ADT with estrogen patch therapy. I'm looking forward to reading the results of the Phase-III PATCH trial in the UK.

Thanks for the good wishes!

Bob

Bourbon2024 profile image
Bourbon2024

see Artera.com and look at ArteraAI Test. See sample test

Lizzo30 profile image
Lizzo30

AI opinions aren't biased

Not what you're looking for?

You may also like...

Decipher and Prolaris and Oncotype...oh my.

In reading about the many uses of these genomic tests, it seems that there is a wide...
TFU589 profile image

Decision Time

Hi All, I recently posted with my situation and have a follow-up (final I hope) with Dr. Gorovets...
MrGreenJeans profile image

"Pros and Cons of Various Forms of Radiation Therapy vs Radical Prostatectomy for Men in Their 50s"

I have been diagnosed with intermediate non-favorable risk prostate cancer. Currently, we are...
Seat15c profile image

Short-term vs Long-Term ADT for High Risk Men

Here's a review of a recent presentation at ASCO 2023 by Artera.ai regarding the use of Artificial...
janebob99 profile image

Long-term adjuvant ADT improves results of brachy boost therapy in unfavorable-risk prostate cancer patients

For most unfavorable risk prostate cancer patients, brachy boost therapy is the preferred option....
Tall_Allen profile image

Moderation team

Bethishere profile image
BethishereAdministrator
Number6 profile image
Number6Administrator
Darryl profile image
DarrylPartner

Content on HealthUnlocked does not replace the relationship between you and doctors or other healthcare professionals nor the advice you receive from them.

Never delay seeking advice or dialling emergency services because of something that you have read on HealthUnlocked.